Archford Capital Strategies’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-756
Closed -$208K – 330
2025
Q2
$208K Sell
756
-3,279
-81% -$892K 0.03% 310
2025
Q1
$1.07M Sell
4,035
-2,159
-35% -$533K 0.16% 139
2024
Q4
$1.44M Buy
6,194
+122
+2% +$28.1K 0.22% 110
2024
Q3
$1.36M Buy
6,072
+585
+11% +$121K 0.21% 112
2024
Q2
$1.08M Buy
+5,487
New +$1.13M 0.17% 123
2019
Q3
– Sell
-2,620
Closed -$509K – 271
2019
Q2
$509K Sell
2,620
-807
-24% -$149K 0.19% 149
2019
Q1
$564K Sell
3,427
-237
-6% -$41.9K 0.21% 137
2018
Q4
$689K Sell
3,664
-145
-4% -$26.8K 0.28% 108
2018
Q3
$648K Sell
3,809
-766
-17% -$129K 0.24% 123
2018
Q2
$750K Buy
+4,575
New +$747K 0.26% 113
2018
Q1
– Sell
-5,280
Closed -$771K – 670
2017
Q4
$771K Buy
5,280
+66
+1% +$9.4K 0.29% 117
2017
Q3
$707K Buy
5,214
+10
+0.2% +$1.26K 0.27% 126
2017
Q2
$652K Buy
5,204
+1,486
+40% +$178K 0.26% 126
2017
Q1
$442K Buy
3,718
+2,320
+166% +$279K 0.17% 155
2016
Q4
$161K Buy
1,398
+1,373
+5,492% +$153K 0.07% 179
2016
Q3
$2K Buy
+25
New +$2.61K ﹤0.01% 522

Other funds holding CME

Archford Capital Strategies's CME Position: Q3 2025 in Review

Archford Capital Strategies sold out of CME Group (CME) in Q3 2025, closing a stake of 756 shares — an estimated $208K sold.

Archford Capital Strategies first reported a position in CME in Q3 2016 and held it in 16 quarters. The position peaked at $1.44M in Q4 2024. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Archford Capital Strategies reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Archford Capital Strategies sold 756 CME Group shares in Q3 2025, an estimated $208K.
  • Archford Capital Strategies first reported a position in CME Group in Q3 2016 and held it in 16 quarters.
  • Archford Capital Strategies's CME Group position peaked at $1.44M in Q4 2024.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Archford Capital Strategies's 13F filing for Q3 2025, filed 17 Oct 2025.